Pregled bibliografske jedinice broj: 1098471
Prostate-specific antigen (PSA) values in patients with low- and high-risk prostatic adenocarcinoma
Prostate-specific antigen (PSA) values in patients with low- and high-risk prostatic adenocarcinoma // Acta clinica Croatica, 58 (2019), Suppl. 2; 12-16 doi:10.20471/acc.2019.58.s2.02 (domaća recenzija, članak, znanstveni)
CROSBI ID: 1098471 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prostate-specific antigen (PSA) values in
patients with low- and high-risk prostatic
adenocarcinoma
Autori
Mašić, Silvija ; Pezelj, Ivan ; Krušlin, Božo
Izvornik
Acta clinica Croatica (0353-9466) 58
(2019), Suppl. 2;
12-16
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Prostatic Adenocarcinoma ; PSA ; Gleason Grade, ; Low-risk ; High-risk
(prostatic adenocarcinoma ; psa ; gleason grade ; low-risk ; high-risk)
Sažetak
Prostatic adenocarcinoma (PC) comprises around 19% of malignancies in Croatian male population. On the basis of PSA value, Gleason score, grading group and clinical stage, PC can be classified into low- and high-risk groups which is significant for different therapeutic regimens and prognostic outcomes. In this retrospective study, we analyzed the difference in preoperative PSA value in a group of 272 patients who underwent radical prostatectomy and were diagnosed with PC adenocarcinoma in our institution in a period from January 1st, 2018 untill December 31st, 2018. Subsequently, they were divided into low- and high-risk prostatic adenocarcinoma groups. Our results demonstrated positive correlation in preoperative PSA values between the groups and therefore support the use
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
